EMA Authorised: Plerixafor Accord (Plerixafor) — Accord Healthcare S.L.U.

View source ↗

Summary

EMA authorised Plerixafor Accord for mobilizing hematopoietic stem cells in adults with multiple myeloma undergoing autologous stem cell transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Plerixafor Accord (Plerixafor)

Snippet

Status: Authorised. Therapeutic area: Multiple Myeloma;Hematopoietic Stem Cell Transplantation. MAH: Accord Healthcare S.L.U.. Decision date: 07/05/2024